Category:
Protein/Antigen/Polypeptide
CAS NO:
/
Standard:
ChP,
Name:
Human Coagulation Factor IX
Category:
Hematology, Critical Illness
Use within:
24 months
Specifications:
500IU/vial, 10ml after redissolution
Approval number:
NMPA Approval No. S20233098
Indications:
Used for bleeding treatment in patients aged 12 and above with factor IX deficiency (hemophilia B).